Nykode Therapeutics Announces Collaboration with The GOG

Potentially registrational VB-C-04 trial in the U.S. expected to initiate 4Q 2023The GOG Foundation, Inc. (GOG) is a U.S. based not-for-profit organization...

Related Keywords

United States ,Oslo ,Norway ,Klaus Edvardsen ,Nykode Vaccibody ,Leslie Randall ,Michael Engsig ,Agnete Fredriksen ,Genentech ,David Geffen School Of Medicine ,Roche Group ,Foundation Inc ,Division Of Gynecologic Oncology ,Oslo Stock Exchange ,Chief Development Officer ,Chief Executive Officer ,Nykode Therapeutics ,Cervical Cancer Advisor ,Ritu Salani ,Gynecologic Oncology ,David Geffen School ,Antigen Presenting Cells ,Adaptive Biotechnologies ,Business Officer ,Oslo Stock Exchange Nykd ,